Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Obesity × Propofol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Gastrointestinal 1

Conditions

Neoplasms 9 Breast Neoplasms 8 Colonic Neoplasms 5 Respiratory Aspiration 3 Prostatic Neoplasms 3 Lung Neoplasms 3 Brain Neoplasms 3 Rectal Neoplasms 2 Pituitary Neoplasms 2 Patient Satisfaction 2 Agnosia 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Supratentorial Neoplasms 1 Stomach Ulcer 1 Stomach Neoplasms 1 Respiration Disorders 1 Rare Diseases 1 Postoperative Complications 1 Postoperative Cognitive Complications 1 Polyps 1 Pain, Postoperative 1 Pain 1 Overweight 1 Obesity 1 Neurofibromatoses 1 Neoplastic Cells, Circulating 1 Myofibroma 1 Melanoma 1 Malignant Neoplasms of Male Genital Organs 1

Interventions

Exercise 13 Metformin 10 Methods 5 Exenatide 5 Diet 5 Nutrition Assessment 4 Diet Therapy 4 Resistance Training 3 Early Intervention, Educational 3 Counseling 3 Caloric Restriction 3 exemestane 2 Yoga 2 Vitamin D 2 Surveys and Questionnaires 2 Sugars 2 Nutritional Status 2 Naltrexone 2 Educational Status 2 Docosahexaenoic Acids 2 Diet, Mediterranean 2 Bupropion 2 Blood Specimen Collection 2 sibutramine 1 rosiglitazone-metformin combination 1 penclomedine 1 licogliflozin 1 dapagliflozin 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Walking 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05518929 2024-06-07

SpO2

RenJi Hospital

Phase 4 Completed

GastrointestinalOther

Obesity, Stomach Neoplasms, Stomach Ulcer, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡